Literature DB >> 31263018

Steady-State Activation and Modulation of the Concatemeric α1β2γ2L GABAA Receptor.

Allison L Germann1, Spencer R Pierce1, Ariel B Burbridge1, Joe Henry Steinbach1, Gustav Akk2.   

Abstract

The two-state coagonist model has been successfully used to analyze and predict peak current responses of the γ-aminobutyric acid type A (GABAA) receptor. The goal of the present study was to provide a model-based description of GABAA receptor activity under steady-state conditions after desensitization has occurred. We describe the derivation and properties of the cyclic three-state resting-active-desensitized (RAD) model. The relationship of the model to receptor behavior was tested using concatemeric α1β2γ2 GABAA receptors expressed in Xenopus oocytes. The receptors were activated by the orthosteric agonists GABA or β-alanine, the allosteric agonist propofol, or combinations of GABA, propofol, pentobarbital, and the steroid allopregnanolone, and the observed steady-state responses were compared with those predicted by the model. A modified RAD model was employed to analyze and describe the actions on steady-state current of the inhibitory steroid pregnenolone sulfate. The findings indicate that the steady-state activity in the presence of multiple active agents that interact with distinct binding sites follows standard energetic additivity. The derived equations enable prediction of peak and steady-state activity in the presence of orthosteric and allosteric agonists, and the inhibitory steroid pregnenolone sulfate. SIGNIFICANCE STATEMENT: The study describes derivation and properties of a three-state resting-active-desensitized model. The model and associated equations can be used to analyze and predict peak and steady-state activity in the presence of one or more active agents.
Copyright © 2019 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31263018      PMCID: PMC6658920          DOI: 10.1124/mol.119.116913

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  28 in total

1.  Allosteric activation mechanism of the alpha 1 beta 2 gamma 2 gamma-aminobutyric acid type A receptor revealed by mutation of the conserved M2 leucine.

Authors:  Y Chang; D S Weiss
Journal:  Biophys J       Date:  1999-11       Impact factor: 4.033

2.  Slow phases of GABA(A) receptor desensitization: structural determinants and possible relevance for synaptic function.

Authors:  Matt T Bianchi; Robert L Macdonald
Journal:  J Physiol       Date:  2002-10-01       Impact factor: 5.182

3.  Two etomidate sites in α1β2γ2 γ-aminobutyric acid type A receptors contribute equally and noncooperatively to modulation of channel gating.

Authors:  Grigori Guitchounts; Deirdre S Stewart; Stuart A Forman
Journal:  Anesthesiology       Date:  2012-06       Impact factor: 7.892

4.  The Actions of Drug Combinations on the GABAA Receptor Manifest as Curvilinear Isoboles of Additivity.

Authors:  Daniel J Shin; Allison L Germann; Joe Henry Steinbach; Gustav Akk
Journal:  Mol Pharmacol       Date:  2017-08-08       Impact factor: 4.436

5.  Mutations in the GABAA receptor that mimic the allosteric ligand etomidate.

Authors:  Stuart A Forman; Deirdre Stewart
Journal:  Methods Mol Biol       Date:  2012

6.  Pregnenolone sulfate block of GABA(A) receptors: mechanism and involvement of a residue in the M2 region of the alpha subunit.

Authors:  G Akk; J Bracamontes; J H Steinbach
Journal:  J Physiol       Date:  2001-05-01       Impact factor: 5.182

7.  Monod-Wyman-Changeux Allosteric Shift Analysis in Mutant α1β3γ2L GABAA Receptors Indicates Selectivity and Crosstalk among Intersubunit Transmembrane Anesthetic Sites.

Authors:  Andrea Szabo; Anahita Nourmahnad; Elizabeth Halpin; Stuart A Forman
Journal:  Mol Pharmacol       Date:  2019-01-29       Impact factor: 4.436

8.  Activation-dependent properties of pregnenolone sulfate inhibition of GABAA receptor-mediated current.

Authors:  Lawrence N Eisenman; Yejun He; Christopher Fields; Charles F Zorumski; Steven Mennerick
Journal:  J Physiol       Date:  2003-08-01       Impact factor: 5.182

Review 9.  Multiple Non-Equivalent Interfaces Mediate Direct Activation of GABAA Receptors by Propofol.

Authors:  Megan M Eaton; Allison L Germann; Ruby Arora; Lily Q Cao; Xiaoyi Gao; Daniel J Shin; Albert Wu; David C Chiara; Jonathan B Cohen; Joe Henry Steinbach; Alex S Evers; Gustav Akk
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363

10.  Correction for Inhibition Leads to an Allosteric Co-Agonist Model for Pentobarbital Modulation and Activation of α1β3γ2L GABAA Receptors.

Authors:  Alexis M Ziemba; Stuart A Forman
Journal:  PLoS One       Date:  2016-04-25       Impact factor: 3.240

View more
  9 in total

1.  Reduced Activation of the Synaptic-Type GABAA Receptor Following Prolonged Exposure to Low Concentrations of Agonists: Relationship between Tonic Activity and Desensitization.

Authors:  Spencer R Pierce; Allison L Germann; Alex S Evers; Joe Henry Steinbach; Gustav Akk
Journal:  Mol Pharmacol       Date:  2020-09-25       Impact factor: 4.436

2.  The Sulfated Steroids Pregnenolone Sulfate and Dehydroepiandrosterone Sulfate Inhibit the α1β3γ2L GABAA Receptor by Stabilizing a Novel Nonconducting State.

Authors:  Spencer R Pierce; Allison L Germann; Joe Henry Steinbach; Gustav Akk
Journal:  Mol Pharmacol       Date:  2021-12-01       Impact factor: 4.436

3.  Perspective on the Relationship between GABAA Receptor Activity and the Apparent Potency of an Inhibitor.

Authors:  Allison L Germann; Spencer R Pierce; Alex S Evers; Joe Henry Steinbach; Gustav Akk
Journal:  Curr Neuropharmacol       Date:  2022       Impact factor: 7.708

4.  Physiological role for GABAA receptor desensitization in the induction of long-term potentiation at inhibitory synapses.

Authors:  Martin Field; Valentina Dorovykh; Philip Thomas; Trevor G Smart
Journal:  Nat Commun       Date:  2021-04-09       Impact factor: 14.919

5.  Markov state models of proton- and pore-dependent activation in a pentameric ligand-gated ion channel.

Authors:  Cathrine Bergh; Stephanie A Heusser; Rebecca Howard; Erik Lindahl
Journal:  Elife       Date:  2021-10-15       Impact factor: 8.140

6.  Steady-state activation and modulation of the synaptic-type α1β2γ2L GABAA receptor by combinations of physiological and clinical ligands.

Authors:  Allison L Germann; Spencer R Pierce; Thomas C Senneff; Ariel B Burbridge; Joe Henry Steinbach; Gustav Akk
Journal:  Physiol Rep       Date:  2019-09

7.  Site-specific effects of neurosteroids on GABAA receptor activation and desensitization.

Authors:  Yusuke Sugasawa; Wayland Wl Cheng; John R Bracamontes; Zi-Wei Chen; Lei Wang; Allison L Germann; Spencer R Pierce; Thomas C Senneff; Kathiresan Krishnan; David E Reichert; Douglas F Covey; Gustav Akk; Alex S Evers
Journal:  Elife       Date:  2020-09-21       Impact factor: 8.140

Review 8.  Druggable Lipid Binding Sites in Pentameric Ligand-Gated Ion Channels and Transient Receptor Potential Channels.

Authors:  Wayland W L Cheng; Mark J Arcario; John T Petroff
Journal:  Front Physiol       Date:  2022-01-04       Impact factor: 4.566

9.  Probing solution structure of the pentameric ligand-gated ion channel GLIC by small-angle neutron scattering.

Authors:  Marie Lycksell; Urška Rovšnik; Cathrine Bergh; Nicolai T Johansen; Anne Martel; Lionel Porcar; Lise Arleth; Rebecca J Howard; Erik Lindahl
Journal:  Proc Natl Acad Sci U S A       Date:  2021-09-14       Impact factor: 11.205

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.